Log in to search using one of your social media accounts:

 

New Fingerprint Test Can Detect Cocaine Use In Seconds
Researchers from the University of Surrey have developed a novel fingerprint drug test that is a remarkable for 2 reasons: it accurately detects metabolites of cocaine within seconds, and positively identifies the user at the same time. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 23, 2017 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Monogamous And Nonmonogamous Men's Brains Respond Differently To Romantic Images
New fMRI study finds that brains of highly monogamous men light up more to romantic images than the brains of highly nonmonogamous men. No such difference in response to sexual images. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 23, 2017 Category: Pharmaceuticals Authors: Zhana Vrangalova, Contributor Source Type: news

Golden 100: Xymogen
This CEO once spent two summers with an uncle who captained a Naval submarine in Key West. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 23, 2017 Category: Pharmaceuticals Authors: Denise Hicks Source Type: news

Janssen receives complete response letter from u.s. fda for sirukumab biologics license application
(Source: Johnson and Johnson)
Source: Johnson and Johnson - September 23, 2017 Category: Pharmaceuticals Source Type: news

Abbott and the Abbott Fund Provide $2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico
- Total support for relief efforts following earthquakes in Mexico and Hurricanes Harvey, Irma and Maria is $4.25 million in products and funding (Source: Abbott.com)
Source: Abbott.com - September 23, 2017 Category: Pharmaceuticals Source Type: news

Amgen Foundation Pledges Up To $5 Million To Hurricane Maria Relief Efforts
Amgen Foundation Pledges $3 Million for Urgent Relief Efforts Amgen Foundation Also Commits up to an Additional $2 Million for Longer-Term Rebuilding Efforts Amgen Staff Disaster Relief Fund Deployed to Assist Puerto Rico-Based Staff THOUSAND OAKS, Calif., Sept. 22, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Amgen Foundation has pledged $3 million to support urgent Hurricane Maria relief efforts in Puerto Rico. The Foundation also has committed up to an additional $2 million for longer-term rebuilding efforts.  Amgen is also activating its Staff Disaster Relief Fund to aid Amg...
Source: Amgen News Release - September 22, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Goldman Sachs on back foot over $7.25bn Avantor debt sale
Investors push back on one of year’s largest leveraged buyout financings (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 22, 2017 Category: Pharmaceuticals Source Type: news

Behind new Obamacare repeal vote: ‘Furious’ Republican donors
The backlash from big donors as well as the grass roots has panicked Senate Republicans and is part of the motivation behind the sudden zeal to take one last crack at repealing the health care law before the end of the month. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: By Carl Hulse Source Type: news

McCain’s ‘no’ vote imperils last-ditch healthcare bill
Trump looks unlikely to have enough support for much-needed legislative win (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 22, 2017 Category: Pharmaceuticals Source Type: news

Healthcare stocks rally after McCain comes out against GOP health bill
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 22, 2017 Category: Pharmaceuticals Source Type: news

Goldman Sachs: a bridge too far
Big fees can cloud underwriting judgment (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 22, 2017 Category: Pharmaceuticals Source Type: news

Former Akebia employee jailed after insider trading prosecutors call him 'unhinged'
Schultz Chan is accused of passing inside information about one of the Cambridge firm's drug trials to another biotech industry employee. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Failed growth hormone trial shrinks Peninsula drug company's stock more than 80%
The company lost more than 80 percent of its value by mid-day Friday after its attempt to tap a $3 billion growth hormone market failed a late-stage clinical trial. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

​Baptist Health South Florida to open new urgent care center in Doral
The health system already operates 17 urgent cares centers across Miami-Dade and Broward counties. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Debora Lima Source Type: news

The District is out 63 obstetrics beds, but here's why health officials aren't worried
D.C. health officials went on record this week about the obstetrics cutbacks at United Medical Center and Providence Health System. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Telemedicine startup expanding to new offices as its client base becomes national
The Troy, New York, company has nearly doubled the number of clients it has nationwide in the past year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Shannon Sweeney Source Type: news

CareFirst CEO Chet Burrell to retire in 2018
Chet Burrell is retiring as president and CEO of CareFirst BlueCross BlueShield, the region ’s largest health insurer, after 10 years in the role. Burrell will leave his post in mid-2018. CareFirst’s board of directors will launch a nationwide search for a replacement to lead the the Owings Mills-based nonprofit insurer, which serves 3.2 million individuals and groups in Maryland, D.C . and Northern Virginia. “A decade of service to the mission of CareFirst has, for me, passed quickly," Burrell… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Miami Valley Hospital to unveil renovated maternity center
Miami Valley Hospital has completed renovations to its maternity center, and will unveil it to the public next month. Renovations to the hospital's Berry Women's Center included new furnishings and lighting, cabinetry in the maternity rooms, and bathrooms. The upgrades bring "a more modern, serene look to the space," and provide families "a more comfortable environment to welcome their baby," according to a press release. The newly renovated facility also includes space for families with infants… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: John Bush Source Type: news

CareFirst CEO Chet Burrell to retire in 2018
Chet Burrell is retiring as president and CEO of CareFirst BlueCross BlueShield, the region ’s largest health insurer, after 10 years in the role. Burrell, 70, will leave his post in mid-2018. The nonprofit's board of directors will launch a nationwide search for Burrell’s replacement. In an announcement to CareFirst employees, Burrell said: “A decade of service to the mission of C areFirst has, for me, passed quickly. No matter the demands, it was never ‘work’ to me, as I felt drawn forward… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Boehringer Ingelheim beefs up St. Joe manufacturing after merger
After closing its mega-merger with Merial this year, Boehringer Ingelheim slowly began ramping up its animal health manufacturing in St. Joseph. The company confirmed that it would increase production capacity as it transfers products from its former Fort Dodge, Iowa, facility. Elanco U.S. Inc. acquired the facility from Boehringer Ingelheim Animal Health in 2016, as well as a portfolio of its vaccine products, for $885 million as part of Boehringer Ingelheim’s acquisition of Merial. The St.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Elise Reuter Source Type: news

Lightstone Ventures raises $250m second fund
Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for. Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance with the Foundry medtech incubator and other strategic partners. The second fund has already made an investment, joining the $30 million Series A round for pharma startup Disarm Therapeutics. “The successful implementation of our strategy requires the ability to ident...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat Lightstone Ventures Venture Capital/Private Equity Source Type: news

Roche receives EU approval of TECENTRIQ ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer
Roche today announced that the European Commission (EC) has granted a marketing authorisation for TECENTRIQ (atezolizumab) as a monotherapy for the treatment of people with locally advanced or metastatic non-small cell lung cancer (NSCLC) after they have been previously treated with chemotherapy regardless of PD-L1 status. (Source: Roche Investor Update)
Source: Roche Investor Update - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives EU approval of TECENTRIQ ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer
Roche today announced that the European Commission (EC) has granted a marketing authorisation for TECENTRIQ (atezolizumab) as a monotherapy for the treatment of people with locally advanced or metastatic non-small cell lung cancer (NSCLC) after they have been previously treated with chemotherapy regardless of PD-L1 status. (Source: Roche Media News)
Source: Roche Media News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain SAN DIEGO, September 22, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) and Brainlab have recon... Devices, Oncology, Neurosurgery Elekta, Brainlab, Versa HD, ExacTrac, stereotactic, radiosurgery, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD
FDA APPROVAL OF MR-CONDITIONAL LABELING FOR THE ELLIPSE™ ICD FAMILY ADDS ANOTHER PATIENT-CENTRIC BENEFIT TO A DEVICE DESIGNED TO OPTIMIZE THE TREATMENT OF ABNORMALLY FAST HEART RHYTHMS ABBOTT PARK, Ill., Sept. 22, 2017 -- (Healthcare Sales & Marketing N... Devices, Cardiology, FDA Abbott, Ellipse ICD, implantable cardioverter defibrillator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

Bayer Appoints Dr. Sharon James Head of Global Innovation and Development for Consumer Health
BASEL, Switzerland, Sept. 22, 2017 -- (Healthcare Sales & Marketing Network) -- Bayer today announced the appointment of Dr. Sharon James as Head of the Global Innovation & Development (I&D) organization of the Consumer Health Division, effective October ... Biopharmaceuticals, Personnel Bayer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 22, 2017 Category: Pharmaceuticals Source Type: news

FT Health: Dispatches from the United Nations
Synthetic opioids, cholera and gender stereotypes (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - September 22, 2017 Category: Pharmaceuticals Source Type: news

Meritech to Showcase Automated Handwashing Systems at Supplyside West
Meritech has announced it will participate as an exhibitor at Supply Side West Global Expo& Conference. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 22, 2017 Category: Pharmaceuticals Source Type: news

Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse ™ ICD
FDA APPROVAL OF MR-CONDITIONAL LABELING FOR THE ELLIPSE ™ ICD FAMILY ADDS ANOTHER PATIENT-CENTRIC BENEFIT TO A DEVICE DESIGNED TO OPTIMIZE THE TREATMENT OF ABNORMALLY FAST HEART RHYTHMS (Source: Abbott.com)
Source: Abbott.com - September 22, 2017 Category: Pharmaceuticals Source Type: news

What Would Graham-Cassidy Do To Transplant Patients?
People with kidney or organ transplants are an overlooked group at grave risk under Graham-Cassidy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 22, 2017 Category: Pharmaceuticals Authors: Judy Stone, Contributor Source Type: news

What Will Graham-Cassidy Do To Transplant Patients?
People with kidney or organ transplants are an overlooked group at grave risk under Graham-Cassidy. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 22, 2017 Category: Pharmaceuticals Authors: Judy Stone, Contributor Source Type: news

Executive profile: Katrina Robinson Lee of The Healthcare Institute LLC
"In all things, growth is the strategy. Whether it is serving your customers, improving operations or growing your bottom line." (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Source Type: news

AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combination of AbbVie's investigational antibody drug conjugate ABBV-399 and Bristol-Myers Squibb's immunotherapy Opdivo (nivolumab) in c-Met overexpressing non-small cell lung cancer (NSCLC). (Source: World Pharma News)
Source: World Pharma News - September 22, 2017 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

Largest Milwaukee-area nursing homes
The List features the largest nursing homes in Milwaukee, Waukesha, Washington, Walworth, Ozaukee, Racine and Kenosha counties ranked by licensed bed capacity. The information is from the 2016 Consumer Information Report from the Wisconsin Department of Health Services. Ties are broken by the average number of patients. The web list features seven additional skilled care facilities. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Source Type: news

Silicon Valley's Answer To Preventing Falls
Every second of every day in the United States an older adult falls. One high-tech company is using artificial intelligence to try to change that. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 22, 2017 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid leukemia (CML), gastrointestinal tumors (GIST) and other rare cancers. The two organizations have been long-time collaborators in providing access to care for patients in lower-income countries through the Glivec International Patient Assistance Program (GIPAP), (Source: World Pharma News)
Source: World Pharma News - September 22, 2017 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Origin's SmartX Nominated for a Third Time
The CPhI Pharma Awards has announced the finalists and Origin Pharma's child-resistant, tamper-evident, blister pack wallet SmartX has been selected for 'Excellence in Pharma: Packaging', making it a hat-trick of finalist nominations in 2017. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 22, 2017 Category: Pharmaceuticals Source Type: news

Mankind Pharma pulls out Navratri-linked ad campaign featuring Sunny Leone
Navratri hoardings campaign was not meant to hurt anyone's sentiments and was immediately withdrawn, said the company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma
Roche announced today that the European Commission has approved Gazyvaro ® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new treatment for previously untreated advanced follicular lymphoma. (Source: Roche Investor Update)
Source: Roche Investor Update - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma
Roche announced today that the European Commission has approved Gazyvaro ® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new treatment for previously untreated advanced follicular lymphoma. (Source: Roche Media News)
Source: Roche Media News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives European approval for Actemra /RoActemra in giant cell arteritis
Roche announced today that the European Commission (EC) has approved Actemra ®/RoActemra® (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and potentially life-threatening autoimmune condition. Actemra/RoActemra is the first therapy approved for the treatment of GCA in Europe. (Source: Roche Investor Update)
Source: Roche Investor Update - September 22, 2017 Category: Pharmaceuticals Source Type: news

Roche receives European approval for Actemra /RoActemra in giant cell arteritis
Roche announced today that the European Commission (EC) has approved Actemra ®/RoActemra® (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and potentially life-threatening autoimmune condition. Actemra/RoActemra is the first therapy approved for the treatment of GCA in Europe. (Source: Roche Media News)
Source: Roche Media News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Pharma stocks in demand as market looks for safety
Analysts now find the risk-reward attractive for large-cap quality pharma stocks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 22, 2017 Category: Pharmaceuticals Source Type: news

Research Shows That Canadian Military Servicemembers and First Responders Struggle to Get Support for Their Own Health Needs
People Who Are on The Frontlines of Trauma are Unaware of Their Risk Factors for Serious Health Conditions (Source: Johnson and Johnson)
Source: Johnson and Johnson - September 22, 2017 Category: Pharmaceuticals Source Type: news

Future Froedtert affiliate United Hospital System plans Pleasant Prairie clinic
United Hospital System in Kenosha, which will soon broaden its partnership with Froedtert& the Medical College of Wisconsin, plans a 50,000-square-foot clinic as part of a new development in Pleasant Prairie. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 22, 2017 Category: Pharmaceuticals Authors: Rich Kirchen Source Type: news

Lessons in Business Continuity
Lessons mined from today's news on business continuity with lessons for supply chain leaders. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 22, 2017 Category: Pharmaceuticals Authors: Lora Cecere, Contributor Source Type: news

Alliance for Safe Online Pharmacies (ASOP Global) Announces Four New...
Gilead Sciences, Inc., the National Alliance on Mental Illness (NAMI), National Council for Behavioral Health (NCBH), and RESOLVE: The National Infertility Association Join Dozens of ASOP Global...(PRWeb September 22, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14725595.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 22, 2017 Category: Pharmaceuticals Source Type: news

M3 Global Research Acquires QQFS (Qualitative & Quantitative...
Leader in global healthcare data collection adds Nordic powerhouse sample provider, QQFS, to their growing global panel portfolio.(PRWeb September 22, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14726722.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 22, 2017 Category: Pharmaceuticals Source Type: news

Forte Announces Winners of the Inaugural Onsemble Rock Star Awards at...
Award winners were revealed, product updates were announced and the community collaborated at the 24th Onsemble conference.(PRWeb September 22, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14725173.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 22, 2017 Category: Pharmaceuticals Source Type: news

Why Scrip Awards Have Shortlisted orphan reach, a CRO That Develops...
orphan reach, a leading Contract Research Organization (CRO) dedicated to the global clinical development of orphan drugs for rare diseases, has been selected as a finalist for the Scrip Awards 2017.(PRWeb September 22, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14711502.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 22, 2017 Category: Pharmaceuticals Source Type: news